Home » News & Thoughts

News & Thoughts

Filter

All Featured News Thoughts Press Releases

Meet our Stakeholders: Primordial Genetics Board Member Todd Mitchell

March 30, 2023

Featured Press Releases

Primordial Genetics Launches High-Performance RNA Polymerases

February 22, 2023

Meet Our Stakeholders: Primordial Genetics Investor Eric Anschutz

August 4, 2022

“Utilizing the Human Genome to Expand Microbial Potential with Primordial Genomics,” Covered by DNA Weekly

August 4, 2022

Meet Maite Arrizubieta

June 28, 2022

Featured Thoughts

Enzymatic Oligo Synthesis

May 31, 2022

Featured Thoughts

Meet Our Stakeholders: Primordial Genetics Investor Greg Mitchell, Ph.D.

May 24, 2022

Meet Nick Halloran

May 17, 2022

Featured Press Releases

Primordial Genetics Awarded $1.06M Phase II SBIR Grant From The National Human Genome Research Institute

April 27, 2022

Meet Chris Schvarcz

April 21, 2022

Meet Patrik Engström

April 4, 2022

Meet Shawn Walsh

October 5, 2021

Meet Matt Goering

September 16, 2021

Meet Barbara Frey

June 17, 2021

Featured Press Releases

Primordial Genetics Grants Arcturus Therapeutics Exclusive License of an RNA Polymerase for Human and Animal Therapeutics

June 2, 2021

Primordial Genetics Receives $55K I-Corps™ at NIH Grant for Enzymatic DNA Synthesis Market Survey

April 29, 2021

Primordial Genetics Hosts YLAI Fellow, María Pía Campot

February 2, 2021

Featured Thoughts

Meet Dan Olson, Ph.D. at Primordial Genetics

October 29, 2020

Meet Karen Xu, Ph.D. at Primordial Genetics

October 1, 2020

Meet Sabrina Baffert at Primordial Genetics

September 8, 2020

Primordial Genetics Awarded $1.15M Grant from the National Institute of General Medical Sciences for Revolutionary Ways to Manufacture Therapeutics and Vaccines

August 6, 2020

Primordial Genetics and Denovium Collaborate to Impact the Diagnosis, Prevention & Treatment of Human Diseases

May 6, 2020

The End of Plastic Waste: How synthetic biology is taking on the garbage patch

April 6, 2020

Featured Thoughts

What is Synthetic Biology?

February 24, 2020

James E. Levine joins Primordial Genetics’ Board of Directors

February 19, 2020

Future-Thinking, Innovative, Inspirational: Plug and Play Startup Graduate

May 20, 2019

Primordial Genetics Granted Two New US Patent

November 5, 2018

Primordial Genetics Awarded National Institutes of Health “America’s Seed Fund” Grant

October 1, 2018

Featured Thoughts

Interview with Primordial Genetics: Founder & President, Helge Zieler, PhD

September 25, 2018

The Science ‘Rebel’ Who’s Teaching Microbes to be More Productive

August 14, 2018

Primordial Genetics presents at BIO World Congress on Industrial Biotechnology conference in Philadelphia, PA

July 16, 2018

Any Organism, Any Trait: Microbial Improvement By Harnessing the Vastness of the Evolutionary Genetic Space

June 20, 2018

Primordial Genetics presents at Synthetic Biology, Engineering, Evolution and Design (SEED) conference in Scottsdale, AZ

June 3, 2018

Primordial Genetics receives NIH Grant: Synthetic biology E. coli strain development for expression of functional human GPCRs with roles in human disease

January 1, 2018

Primordial Genetics presents its technology and goals at Synthetic Biology Australasia, Sydney, Australia. Rapid evolution of yeast and bacteria by combinatorial assembly and selection of compound genes created from native coding sequences

September 21, 2017

Primordial Genetics presents at SynBiobeta Conference in London, UK

April 4, 2017

News Press Releases

Primordial Genetics and Bayer announce research collaboration to enhance crop performance

November 24, 2016

Primordial Genetics attends ABLCNext Conference in San Francisco, CA

November 4, 2016

Poster Presentation at Synbiobeta Conference by Sabrina German

October 5, 2016

Primordial Genetics attends Synbiobeta Conference in San Francisco, CA

October 4, 2016

Primordial Genetics attends the Global AgInvesting AgTech Week investor conference in San Francisco, CA

June 21, 2016

Primordial Genetics attends BIO International Convention in San Francisco, CA

June 6, 2016

Poster presentation at the BIO World Congress on Industrial Biotechnology by Justin Stege, Director of Industrial Biotechnology

April 18, 2016

Primordial Genetics signs R&D Agreement for pharmaceutical manufacturing

March 30, 2016

Primordial Genetics launches FOMO-21 high-solubility E. coli. protein expression strain

January 11, 2016

Primordial Genetics moves into new facility at 3550 General Atomics Court

December 21, 2015

News Press Releases

Primordial Genetics and Abilita Bio Establish Collaboration to Produce Stabilized G Protein-Coupled Receptors (GPCRs) in Bacteria

December 14, 2015

Primordial Genetics launches enzyme improvement project for pharmaceutical manufacturing

November 18, 2015

Primordial Genetics receives Notice of Allowance from USPTO covering Function Generator combinatorial genetics technology

July 23, 2015

Company presentation at the 2015 BIO 12th Annual World Congress on Industrial Biotechnology

July 21, 2015

Investor presentation at the 2015 BIO 12th Annual World Congress on Industrial Biotechnology

July 20, 2015

Richard Schneeberger PhD, MBA joins Primordial Genetics as business consultant

April 1, 2015

Primordial Genetics closes new financing round and adds private equity investors

January 1, 2015

Alan Greener joins Primordial Genetics as Vice President, Research and Development

January 1, 2015

Company presentation at the 2014 BIO Pacific Rim Summit in San Diego

December 9, 2014

Egle Thomas PhD, MBA joins Primordial Genetics as business consultant.

September 5, 2014

Company presentation at the 2014 Yeast Genetics Meeting in Seattle

August 1, 2014

San Diego Hosts World’s Largest Biotechnology Convention

June 21, 2014

Primordial Genetics Inc launches R&D operations

July 29, 2013

Primordial Genetics Inc. awarded a National Science Foundation Phase I STTR grant

July 1, 2013

Primordial Genetics Inc. invited to join the JLABS biotechnology incubator (formerly Janssen Labs) in San Diego

May 9, 2013

© 2023 Primordial Genetics.